1.Efficient reprogramming of human cord blood CD34(+) cells for formation of induced pluripotent stem cells with non-integrating plasmid system.
Quan-E ZHANG ; Shu-Ping LIU ; Yan-Feng LIU ; Hong-Yan ZHANG ; Wei-Ping YUAN ; Gui-Bin CHEN ; Yan-Xin LI ; Jing XU
Journal of Experimental Hematology 2013;21(3):728-734
This study was to establish the episomal vector reprogramming method to reprogram iPSC from human cord blood (CB) CD34(+) cells. The non-integrating plasmids of pEB-C5 and pEB-Tg were transfected into short-term cultured CB CD34(+) cells by using the nucleofector, so as to demonstrate efficient reprogramming of CB CD34(+) cells. Within 14 days of one-time transfection by two plasmids together, up to 200 iPSC-like colonies per 2 million transfected CB CD34(+) cells were generated. The results showed that the pluripotency of iPSC-derived CB CD34(+) cells was similar to that of hESC and the karyotypes of iPSC were normal. In addition, no vector integration was found in iPSC of 9th and 10th passages. Furthermore, hiPSC formed teratoma with three embryonic germ layers. It is concluded that the integration-free method to generate human iPSC from CB CD34(+) cells is reliable and can provide new ways for both research and future clinical applications.
Animals
;
Antigens, CD34
;
immunology
;
Cell Culture Techniques
;
Cells, Cultured
;
Cellular Reprogramming
;
Fetal Blood
;
cytology
;
immunology
;
Fibroblasts
;
cytology
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
Mice
;
Plasmids
2.Human embryonic stem cells and therapeutic cloning.
Woo Suk HWANG ; Byeong Chun LEE ; Chang Kyu LEE ; Sung Keun KANG
Journal of Veterinary Science 2005;6(2):87-96
The remarkable potential of embryonic stem (ES) cells is their ability to develop into many different cell types. ES cells make it possible to treat patients by transplanting specialized healthy cells derived from them to repair damaged and diseased cells or tissues, known as "stem cell therapy". However, the issue of immunocompatibility is one of considerable significance in ES cell transplantation. One approach to overcome transplant rejection of human ES (hES) cells is to derive hES cells from nuclear transfer of the patient's own cells. This concept is known as "therapeutic cloning". In this review, we describe the derivations of ES cells and cloned ES cells by somatic cell nuclear transfer, and their potential applications in transplantation medicine.
Animals
;
Cell Culture Techniques/*methods
;
Cloning, Organism/*methods
;
Embryo/cytology
;
Embryo Culture Techniques
;
Humans
;
Pluripotent Stem Cells/*cytology/immunology
;
Stem Cell Transplantation/*methods